Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRAS mutation identified in a patient with melorheostosis and extended lymphangiomatosis treated with sirolimus and trametinib.

Clinical genetics - 1 Oct 2021

Lacasta-Plasin Clara, Martinez-Glez Victor, Rodriguez-Laguna Lara, Cervantes-Pardo Antonio, Martinez-Menchon Teresa, Sanchez-Jimenez Regina, Campos-Dominguez Minia

Abstract excerpt

Detection of KRAS mutation in skin biopsy in a patient with melorheostosis, lymphantiomatosis and vascular stenosis. She was successfully treated with trametinib.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Biopsy
Share to Disease Management

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Pyridones

Share to Pyrimidinones

Share to Sirolimus

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 34190333
DOI: 10.1111/cge.14018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRAS mutation identified in a patient with melorheostosis and extended lymphangiomatosis treated with sirolimus and trametinib.PMID 34190333Read ↗

Life-threatening Lymphatic Malformation With Somatic Activating NRAS Mutation Successfully Treated With Trametinib: A Case StudySemantic proximity Read ↗

KRAS-driven model of Gorham-Stout disease effectively treated with trametinibSemantic proximity Read ↗

Mosaic RASopathy due to KRAS variant G12D with segmental overgrowth and associated peripheral vascular malformations.Semantic proximity Read ↗

Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibitionSemantic proximity Read ↗

Novel findings and expansion of phenotype in a mosaic RASopathy caused by somatic KRAS variants.Semantic proximity Read ↗

Inguinal lymph nodes agenesia in a patient with Schimmelpenning-Feuerstein-Mims syndrome with proven somatic KRAS mutation.Semantic proximity Read ↗

A somatic activating KRAS variant identified in an affected lesion of a patient with Gorham-Stout disease.Semantic proximity Read ↗

Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.Semantic proximity Read ↗

Somatic NRAS mutation in patient with generalized lymphatic anomaly.Semantic proximity Read ↗

Mosaic KRAS mutations cause an atypical variant of phacomatosis spilosebacea.Semantic proximity Read ↗

Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibition.Semantic proximity Read ↗

Cutaneous involvement in an 8-year-old boy with Ras-associated autoimmune leucoproliferative disorder (RALD).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.